Testing a Vibration Glove for Recovery After Chronic Stroke
Tests a vibrating glove device against a sham version in people with chronic stroke.
Plain-language title generated from the registry record
Registry title: Vibrotactile Coordinated Reset for the Treatment of Chronic Stroke
Key facts
- Where
- Stanford, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Source: NCT05490277, who can take part
Where in United States
- Stanford UniversityStanford, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Stanford University
- Trial code
- NCT05490277
- Record updated
- 15 May 2025
- Original description
The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on motor ability within stroke patients. vCR will be administered with a device called the Vibrotactile (VT) Brain Glove. vCR is expected to provide patients with a non-invasive therapy to aid in recovery from a stroke. This study will include a dedicated sham arm that will aid in understanding true treatment effects from vCR.Read full original descriptionShow less
Vibrotactile Coordinated Reset for the Treatment of Chronic Stroke
The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on motor ability within stroke patients. vCR will be administered with a device called the Vibrotactile (VT) Brain Glove. vCR is expected to provide patients with a non-invasive therapy to aid in recovery from a stroke. This study will include a dedicated sham arm that will aid in understanding true treatment effects from vCR.
Inclusion: Age at the time of enrollment: 18-80 years; Diagnosis of ischemic or hemorrhagic stroke; Disease period of more than 6 months; Mini Mental State Examination of at least 24 points; No medications that affect balance; Motor deficit; Use of Motricity Arm and Leg index to include impaired individuals with some functioning; Modified Rankin Scale for Neurologic Disability: Scores 3 or 4.
Exclusion: Any current drug or alcohol abuse; Participation in another drug, device or biologic trial concurrently or within the preceding days; Botox, baclofen or any other treatment for spasticity except for bracing or splinting within the previous 3 months; Any significant psychiatric problems, including acute confusional state (delirium), ongoing psychosis, or clinically significant depression; History of recurrent or unprovoked seizures; Any neurological disorder treatments that involve intracranial surgery or device implantation; History or presence of other major neurological or orthopedic diseases other than stroke that limits motor functioning or cognitive ability; Pregnancy, breastfeeding or wanting to become pregnant during the trial; More than 5 degrees of contracture at shoulder, elbow, wrist, finger, hip, knee, or ankle; Must be able to communicate with staff; Severe sensory abnormalities of the fingers such as vibratory urticaria.